DE3620647A1 - Verfahren zur herstellung von 2-halogen-nicergolinen - Google Patents

Verfahren zur herstellung von 2-halogen-nicergolinen

Info

Publication number
DE3620647A1
DE3620647A1 DE19863620647 DE3620647A DE3620647A1 DE 3620647 A1 DE3620647 A1 DE 3620647A1 DE 19863620647 DE19863620647 DE 19863620647 DE 3620647 A DE3620647 A DE 3620647A DE 3620647 A1 DE3620647 A1 DE 3620647A1
Authority
DE
Germany
Prior art keywords
nicergoline
halogen
general formula
addition salts
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19863620647
Other languages
German (de)
English (en)
Inventor
Gabor Dr Megyeri
Tibor Dr Keve
Bela Dr Stefko
Erik Bogsch
Janos Dr Galambos
Geb Zieger Kassai
Ferenc Dr Trischler
Eva Dr Palosi
Dora Dr Groo
Egon Dr Karpati
Zsolt Dr Szombathelyi
Laszlo Dr Szporny
Bela Kiss
Istvan Dr Laszlovszky
Erzsebet Lapis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE3620647A1 publication Critical patent/DE3620647A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19863620647 1985-06-21 1986-06-20 Verfahren zur herstellung von 2-halogen-nicergolinen Withdrawn DE3620647A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852447A HU193782B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof

Publications (1)

Publication Number Publication Date
DE3620647A1 true DE3620647A1 (de) 1987-01-02

Family

ID=10959403

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19863620647 Withdrawn DE3620647A1 (de) 1985-06-21 1986-06-20 Verfahren zur herstellung von 2-halogen-nicergolinen

Country Status (30)

Country Link
US (1) US4753949A (enExample)
JP (1) JPS62485A (enExample)
CN (1) CN1015365B (enExample)
AR (1) AR241533A1 (enExample)
AT (1) AT390614B (enExample)
AU (1) AU594686B2 (enExample)
BE (1) BE904957A (enExample)
CH (1) CH671018A5 (enExample)
CS (1) CS255875B1 (enExample)
DD (1) DD246111A5 (enExample)
DE (1) DE3620647A1 (enExample)
DK (1) DK292086A (enExample)
ES (1) ES8800953A1 (enExample)
FI (1) FI84605C (enExample)
FR (1) FR2583756B1 (enExample)
GB (1) GB2176788B (enExample)
HU (1) HU193782B (enExample)
IL (1) IL79179A0 (enExample)
IN (1) IN163116B (enExample)
IT (1) IT1204865B (enExample)
LU (1) LU86485A1 (enExample)
NL (1) NL8601612A (enExample)
NO (1) NO164099C (enExample)
PH (1) PH24732A (enExample)
PL (1) PL147390B1 (enExample)
PT (1) PT82808B (enExample)
SE (1) SE463716B (enExample)
SU (1) SU1445557A3 (enExample)
YU (1) YU107986A (enExample)
ZA (1) ZA864633B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) * 1962-06-11 1966-01-11 Lumilysergol derivatives
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
EP0091652B1 (en) * 1982-04-13 1986-02-26 FARMITALIA CARLO ERBA S.p.A. Ergoline derivatives, process for producing the ergoline derivatives and pharmaceutical compositions containing them
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives

Also Published As

Publication number Publication date
SE8602737L (sv) 1986-12-22
PT82808A (en) 1986-07-01
SE463716B (sv) 1991-01-14
NO862493L (no) 1986-12-22
FI862635A7 (fi) 1986-12-22
JPS62485A (ja) 1987-01-06
ZA864633B (en) 1987-02-25
HU193782B (en) 1987-11-30
AR241533A1 (es) 1992-08-31
SU1445557A3 (ru) 1988-12-15
ES8800953A1 (es) 1987-12-16
US4753949A (en) 1988-06-28
FR2583756B1 (fr) 1990-01-12
DK292086A (da) 1986-12-22
CN1015365B (zh) 1992-02-05
FI862635A0 (fi) 1986-06-19
IL79179A0 (en) 1986-09-30
DK292086D0 (da) 1986-06-20
SE8602737D0 (sv) 1986-06-19
YU107986A (en) 1988-04-30
IN163116B (enExample) 1988-08-13
PL147390B1 (en) 1989-05-31
FI84605B (fi) 1991-09-13
AU594686B2 (en) 1990-03-15
GB2176788A (en) 1987-01-07
PT82808B (pt) 1988-04-21
LU86485A1 (de) 1986-12-02
IT1204865B (it) 1989-03-10
GB2176788B (en) 1989-07-26
FI84605C (fi) 1991-12-27
AT390614B (de) 1990-06-11
NL8601612A (nl) 1987-01-16
ES556359A0 (es) 1987-12-16
IT8620873A0 (it) 1986-06-20
HUT41024A (en) 1987-03-30
NO164099C (no) 1990-08-29
FR2583756A1 (fr) 1986-12-26
CH671018A5 (enExample) 1989-07-31
PH24732A (en) 1990-10-01
NO862493D0 (no) 1986-06-20
AU5891686A (en) 1986-12-24
DD246111A5 (de) 1987-05-27
ATA168486A (de) 1989-11-15
GB8615120D0 (en) 1986-07-23
CN86104086A (zh) 1986-12-17
JPH0529227B2 (enExample) 1993-04-28
CS255875B1 (en) 1988-03-15
BE904957A (fr) 1986-12-19
NO164099B (no) 1990-05-21

Similar Documents

Publication Publication Date Title
DE2516025A1 (de) Neue pyridinderivate, ihre herstellung und verwendung
EP0207331A1 (de) Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE1795022C3 (de) Lysergsäurederivate
DE69005861T2 (de) Benzoxepin-Derivate.
DE1804691C3 (de) Taurocholensäurederivate
DE2624789A1 (de) Eburnameninderivate und verfahren zu ihrer herstellung
DE3020695C2 (enExample)
EP0405298B1 (de) Thienopyran-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
EP0155903A1 (de) Indolophenanthridine, ihre Herstellung und Verwendung
DE2757858C2 (enExample)
DE2223681A1 (de) Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung
AT390614B (de) Verfahren zur herstellung von neuen 2-halogen-nicergolinen
DE2719916C2 (de) Verfahren zur Herstellung von 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decanen
DE69623656T2 (de) Trans apovincaminsäure-esterderivate als arzneimittel
DE3619617A1 (de) Verfahren zur herstellung von 2-brom-(alpha)-ergokryptin
DE69102310T2 (de) Pyridylsulfonylharnstoff- und Pyridylsulfonylthioharnstoff-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
CH615182A5 (enExample)
DE3002366A1 (de) Neue phenylaethylaminderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE1205094B (de) Verfahren zur Herstellung von 17alpha-Aminosteroiden der Androstenreihe
DE3620487A1 (de) 10(alpha)-methoxy-6-methlergolin-derivate, verfahren zu deren herstellung und arzneimittelpraeparate
DD290887A5 (de) Neue rifamycinderivate
WO1983002775A1 (en) Ergot alkaloids, manufacturing process thereof and pharmaceutical preparations containing them
DE3119514C2 (enExample)
CH629803A5 (en) Process for preparing a new alkaloid of the vincamine type and salts thereof
DE2710807C2 (de) Benzylamino-alkancarboxamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee